oncogene-driven changes in the metabolism of glutathione

oncogene-driven changes in the metabolism of glutathione Simplified illustration on S. cerevisiae Glutathione-Dependent Pathways in Cancer Cells

Name: oncogene-driven changes in the metabolism of glutathione Simplified illustration on S. cerevisiae Glutathione-Dependent Pathways in Cancer Cells
Brand: crisbcreativa.com
SKU: 27657908871
Price: 26.60 USD
Availability: InStock
Rating: 4.7362 (16 reviews)

Glutathione Dependent Pathways in Cancer Cells Unraveling the Potential Role of Glutathione in Multiple Forms of Cell Death in Cancer Therapy Lv 2019 Oxidative Medicine and Cellular Longevity Wiley Online Library Glutathione peroxidase 4dependent glutathione highconsumption drives acquired platinum chemoresistance in lung cancerderived brain metastasis Liu 2021 Clinical and Translational Medicine Wiley Online Library Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies Targeting glutamine metabolism as a potential target for cancer treatment Journal of Experimental & Clinical Cancer Research Springer Nature Link

SKU: 27657908871 · From crisbcreativa.com

4.7

USD26.60 USD76.60

Pay in 4 interest-free payments of $6.65 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

S.QueF.WangF.et al

oncogene-driven changes in the metabolism of glutathione Simplified illustration on S. cerevisiae Glutathione-Dependent Pathways in Cancer Cells

The Swiss Chems shipping terms are as follows: Both domestic (USA and Canada) and international shipping is available

While the nanotechnology is a potent field for cancer therapeutics, there have been concerns for toxicity in dosing and the propensity to incite inflammation and worsen respiratory and cardiovascular disease

Nitric oxide appears to influence Akt signaling though a cGMP/PI3K-dependent pathway [8], which is the primary pathway for up-regulating translation initiation and MPS

Early-stage literature suggests activity in growth factor signaling pathways, though clinical efficacy in humans remains limited and largely investigational